Shown verbatim: the complete text as captured from the official page posted by the Virginia General Assembly, fetched 2026-08-29. Where this bill amends existing law, language marked for deletion in the official page appears here in brackets. This is the chaptered version. The official bill page.
CHAPTER 306 An Act to direct the Board of Pharmacy to reschedule psilocybin upon federal scheduling changes. [S 379] Approved April 6, 2026 Be it enacted by the General Assembly of Virginia: 1. § 1. Upon approval by the U.S. Food and Drug Administration (FDA) of a formulation of psilocybin designed to be administered by a health care professional in a health care setting, the Board of Pharmacy shall reschedule such formulation of psilocybin consistent with federal scheduling changes and procedures contained in subsection E of § 54.1-3443 of the Code of Virginia at its next quarterly meeting following the expiration of 30 days from publication in the Federal Register of a final or interim final order or rule designating any formulation of psilocybin that has been approved by the FDA as a controlled substance.
Every fact on this page links to its source, starting with the official bill record.